GENFIT Stock Other OTC
Stocks
GNFTF
FR0004163111
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 527M 603M 484M 451M 855M 57.4B 870M 5.82B 2.26B 28.15B 2.26B 2.21B 97.01B | P/E 2025 |
-3.06x | P/E 2026 * | 55.6x |
|---|---|---|---|---|---|
| Enterprise Value | 472M 540M 434M 404M 766M 51.44B 779M 5.22B 2.02B 25.23B 2.03B 1.98B 86.93B | EV / Sales 2025 |
2.34x | EV / Sales 2026 * | 5.04x |
| Free-Float |
86.88% | Yield 2025 * |
-
| Yield 2026 * | - |
| 1 day | -3.28% |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Prigent
CEO | Chief Executive Officer | 58 | 2019-09-15 |
Thomas Baetz
DFI | Director of Finance/CFO | 52 | 2021-04-21 |
Pejvack Motlagh
CTO | Chief Tech/Sci/R&D Officer | - | 2025-11-26 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 70 | 2017-06-15 | |
| Director/Board Member | 54 | 1999-09-14 | |
| Director/Board Member | 58 | 2017-06-15 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.28% | -.--% | - | - | 603M | |
| +0.36% | +5.10% | +1.04% | +5.85% | 49.15B | |
| +0.92% | +6.21% | +408.85% | +607.44% | 40.23B | |
| +1.89% | +11.06% | +25.75% | -7.89% | 34.55B | |
| +2.38% | +8.10% | +21.83% | +66.94% | 33.09B | |
| +1.20% | +2.02% | +9.79% | +32.43% | 25.19B | |
| +2.51% | +4.94% | - | - | 17.05B | |
| +2.58% | +7.24% | +71.03% | +132.17% | 15.92B | |
| +0.99% | +1.26% | +13.98% | +18.88% | 13.83B | |
| -1.14% | +7.52% | +14.75% | -30.83% | 13.26B | |
| Average | +0.84% | +6.43% | +70.87% | +103.12% | 26.92B | |
| Weighted average by Cap. | +1.27% | +6.73% | +88.26% | +130.73% |
| 2025 | 2026 * | |
|---|---|---|
| Net sales | 66.82M 76.47M 61.36M 57.22M 108M 7.28B 110M 739M 286M 3.57B 287M 281M 12.3B | 95.2M 109M 87.42M 81.52M 155M 10.37B 157M 1.05B 408M 5.09B 409M 400M 17.53B |
| Net income | -8.3M -9.5M -7.62M -7.11M -13.48M -905M -13.71M -91.79M -35.57M -444M -35.68M -34.9M -1.53B | 18.31M 20.95M 16.81M 15.68M 29.72M 1.99B 30.22M 202M 78.44M 978M 78.66M 76.95M 3.37B |
| Net Debt | -54.72M -62.62M -50.25M -46.86M -88.83M -5.96B -90.33M -605M -234M -2.92B -235M -230M -10.08B | -46.87M -53.64M -43.04M -40.13M -76.09M -5.11B -77.37M -518M -201M -2.5B -201M -197M -8.63B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
